Tonghua Golden-Horse Pharmaceutical Industry's (SHE:000766) stock fluctuated more than 20% for two straight trading sessions on June 29 and 30, according to a Wednesday filing with the Shenzhen bourse.
The stock movement coincided with the approval of its anveracrine succinate tablets for mild to moderata Alzheimer's, the filing said.
Shares closed 2% lower on Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments